Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 3,275

Document Document Title
WO/2017/149052A1
The invention pertains to a process for producing a compound of formula (11) wherein R7 and R8 are each independently selected from H, halogen, alkyl, aryl, or alkylaryl, R42 is H or a protective group, R43 is H or R3, wherein R3 is a pr...  
WO/2017/145022A1
Described herein are UV-absorbing vinylic monomers conjugated to 2-aminobenzophenone derivatives and their uses in preparing UV-absorbing contact lenses capable of blocking ultra-violet ("UV") radiation and violet radiation with waveleng...  
WO/2017/147386A1
The present disclosure is directed to, e.g., 3-substituted, 5-amine-substituted-cyclohex-2-en-1-one compounds, and method of treatment and making associated with the same compounds.  
WO/2017/067497A3
Disclosed are a monosubstituted or polysubstituted amphiphilic hypocrellin derivative, preparation method therefor, and uses thereof. In the present invention, the amphiphilic hypocrellin derivative having substituted functional groups s...  
WO/2017/138838A1
The invention relates to salts and hydrates of arylcycloalkylamine derivatives of general formula (I) and formula (II), where in formula (I), R1 and R2 signify H, a linear or branched alkyl (C1, C4), a linear or branched alkoxy (C1, C4),...  
WO/2017/138363A1
The present invention provides an organic photoelectric conversion element (1) which comprises an electron collecting electrode (13), a hole collecting electrode (14), and a photoelectric conversion part arranged between the electron col...  
WO/2017/129759A1
The present invention concerns new halogen substituted diketone compounds, new pyrazole compounds, processes for the manufacture of pyrazole compounds and processes for the manufacture of agrochemical or pharmaceutical compounds.  
WO/2017/101791A1
Disclosed are a compound and a use thereof in preparing a drug, and in particular, provided in the present invention are: the compound as shown in formula (I) or a stereoisomer, a geometric isomer, a tautomer, a racemate, a nitroxide, a ...  
WO/2017/087607A1
Compounds are provided as chemokine inhibitors having the structure: Formula (A).  
WO/2017/087388A1
Phenyl cyclohexanone based active agents, pharmaceutical preparations containing such active agents, methods of modifying cellular activity by contacting cells with such active agents, and methods of treating various conditions by admini...  
WO/2017/082144A1
The present invention provides a compound represented by formula (I), or a pharmaceutically acceptable salt or prodrug thereof. The present invention also provides: a composition which includes the compound represented by formula (I), or...  
WO/2017/081590A1
The present invention provides a process for preparing omarigliptin.  
WO/2017/077550A1
The present invention discloses a novel metal free process for the regioselective synthesis of α-substituted carbonyl compounds of formula I from alkene, X is selected from the following compounds (A, B).  
WO/2017/078332A1
The present invention relates to a method for forming a three-dimensional object. According to the present invention, when the three-dimensional object is manufactured by an inkjet method, a support can be removed without damage to a str...  
WO/2017/067634A1
The invention relates to the use of hydrophilic compounds of formula (I) as photopolymerization initiators of polymerizable substance mixtures, which contain unsaturated compounds, or to the photochemical cross-linking of linear polymers...  
WO/2017/057460A1
Provided is a method for producing an organic compound, wherein the organic compound is an industrially useful compound, and a deodorization step, for removing from a reaction solution odorants that are generated in or remaining after a ...  
WO/2017/054112A1
The present invention relates to a method of preparing a 3-fluoroalkyl-1-methylpyrazole-4-carboxylic acid comprising the following steps: Step 1, performing a condensation reaction on the fluoroacetyl halide derivative shown in formula I...  
WO/2017/043175A1
Provided is a near-infrared absorbing curable composition which is capable of forming a cured film that has excellent infrared light shielding properties and visible light transparency, while exhibiting excellent heat resistance and ligh...  
WO/2017/035665A1
The present application is directed to transdermal formulations for the delivery of doxycycline compounds to a subject for the treatment of doxycycline-responsive diseases. In particular, the transdermal formulation is an emulsion compri...  
WO/2017/035224A1
Highly efficient methods for synthesis of levomethadone hydrochloride or dextromethadone hydrochloride are provided starting from D-alanine, or L-alanine, respectively, with retention of configuration. Methods for treating a subject are ...  
WO/2016/207252A1
A method of preparing a compound represented by general formula (3) : Formula (3). R1 and R2 are each independently an alkyl group. The method includes reacting a compound represented by general formula (2) : Formula (2) with an alkylami...  
WO/2016/202254A1
Provided are a preparation method for synthesizing a pyrazolecarboxylic acid derivative of the following formula (I), which is suitable for industrial production, and an intermediate as shown by the following formula (II). The method is ...  
WO/2016/197730A1
The present invention relates to an organic electroluminescent material, which has a structure as represented by formula (I). Compounds as represented by formula (I) have highly stable electron acceptor groups and electron donor groups, ...  
WO/2016/180984A1
The present invention is directed to processes for the preparation of esketamine. The present invention is further directed to processes for the resolution of S-ketamine from a racemic or enantiomerically enriched mixture of ketamine. Th...  
WO/2016/150208A1
Disclosed are a pharmaceutical composition and dosage form containing a glaucocalyxin A derivative as represented by the formula (I) or salt thereof, and a preparation method and use of said composition and dosage form; the anti-autoimmu...  
WO/2016/150206A1
Disclosed is a glaucocalyxin A derivative -- dimethylamino glaucocalyxin A hydrochloride salt -- and two crystalline forms thereof. The dimethylamino glaucocalyxin A hydrochloride salt provided by the present invention has good water sol...  
WO/2016/150207A1
Provided is a glaucocalyxin A derivative, or salt thereof, as represented by the formula (I), a method for preparation of said glaucocalyxin A derivative, and a use for said glaucocalyxin A derivative in preparing pharmaceuticals for fig...  
WO/2016/152886A1
The present invention provides a novel method for producing pyrazole derivatives useful as intermediates of pharmaceuticals and agricultural chemicals, as well as novel intermediate compounds in this method. The present invention pertain...  
WO/2016/136963A1
 Provided is a method for producing, through chemical synthesis, kakeromycin and derivatives thereof which exhibit antifungal activity and cytotoxicity, and are expected to serve as novel antifungal agents or anticancer agents. Said me...  
WO/2016/113763A1
A novel antileishmanial formulation containing compounds belonging to the series of (2Z,2'Z)-3,3'-(alkane-1,2-diylbis(azanediyl))bis(6-hydroxy-1 - aryl/fluorenyl hex-2-en-1-ones) or their salts thereof showing antileishmanial activity un...  
WO/2016/103274A1
The present invention discloses an improved process for preparing pure (dimethylarnino)-4,4-diphenyl-3-heptanone and its hydrochloride salt.  
WO/2016/071249A1
The present invention relates to a novel method for producing substituted biphenylamines.  
WO/2016/073653A1
The present invention is directed to novel neuro-attentuating norketamine (NANKET) compounds according to any one of formulas (I - shown below), (I-A) and (I-B), or any of the compounds described in Tables A-D, or in any of the Examples ...  
WO/2016/062585A1
The present invention relates to a compound of formula (I) wherein: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and G are as defined herein; and wherein the compound of formula (I) is optionally present as an agrochemically acce...  
WO/2016/027757A1
The present invention addresses the problem of providing a novel compound for realizing an effect on a therapeutic and/or preventive drug for mental illnesses, such as depression, atypical depression, treatment-resistant depression, anxi...  
WO/2015/027160A3
The present technology relates to compounds and compositions of Formulas I, II, VII, and VIII, and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of addiction, me...  
WO/2015/158381A1
The present invention relates to novel cannabidiol quinone derivatives of formula (I) (I) wherein R is the carbon atom of a, linear or branched group, represented by: alkyl, aryl, alkenyl, alkynyl, acyl or alkoxycarbonyl groups; or where...  
WO/2015/139859A1
Object of the present invention is an improved process for the preparation of key intermediates for the synthesis of the active pharmaceutical ingredient named Omarigliptin.  
WO/2015/128200A1
The present invention relates to novel cannabigerol quinone derivatives of formula (I) wherein R is the carbon atom of a linear or branched group, represented by: aryl, alkenyl, alkynyl or alcoxycarbonil groups; or wherein R is the nitro...  
WO/2015/109963A1
Disclosed are an o-phenyl chalcone compound and preparation method and use thereof The o-phenyl chalcone compound is capable of inhibiting the aggregation assembly of microtubules in tumour cells and influencing the mitosis of the cells,...  
WO/2015/093177A1
The present invention provides a ruthenium compound (a precursor) which can be used in a chemical vapor deposition method, particularly an ALD method, and which has good reactivity with a reactive gas, a high vapor pressure and a low mel...  
WO/2014/198880A1
The invention provides a compound of formula (I) wherein R2-R10 represent different meanings, and pharmaceutically acceptable salts thereof. The invention also provides synthetic procedures for preparing the compounds of formula (I), pha...  
WO/2008/043911A3
The invention relates to dendritic chelated compounds, to methods for producing the same and to pharmaceutical compositions containing the same. The dendritic chelated complexes of the present invention have the following formula (I): [[...  
WO/2014/156184A1
[Problem] To provide: an organic photoelectric conversion element which has good response speed, carrier transport properties (sensitivity) and heat resistance; and an imaging element which is provided with this organic photoelectric con...  
WO/2014/125918A1
A sublimation and purification device having a sublimation tube, a vacuum pump, and piping that connects the sublimation tube and the vacuum pump. The sublimation tube has a conductance (KAC) from A to C of at least 0.01 m3/s, when A is ...  
WO/2014/125917A1
A sublimation purification method using a sublimation purification device having a sublimation tube, a vacuum pump and piping for connecting said sublimation tube and vacuum pump, wherein: one end of the sublimation tube is closed and th...  
WO/2014/118038A1
The invention relates to novel phosphorus ligands and to a chemoselective and regioselective method for the hydroaminomethylation of olefins with at least one primary or secondary amine, with the addition of H2 and CO under catalytic con...  
WO/2014/096474A1
The invention relates to the use of a chromogenic compound, called compound 1, for the detection of the cyanide anion (CN), both in a gaseous state, from the HCN compound, and in a solution, preferably in an aqueous solution. The inventi...  
WO/2014/082581A1
Disclosed is an α-(3, 5-dimethoxy benzylidene)-α'-hydrocarbyl methylene cyclic ketone, having a structure as represented by (I) or (II), wherein R is an aryl or alkyl; a preparation method is: mixing cyclic ketone and morpholine, and a...  
WO/2014/072371A1
The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer hematological mal...  

Matches 51 - 100 out of 3,275